002923SZSE

Announcement on Obtaining Drug Registration Certificate for Isosorbide Dinitrate Injection

Rundu Co., Ltd.·June 22, 2026·2 pages

✨ AI Summary

Zhuhai Rundu Pharmaceutical Co., Ltd. announced it has received a drug registration certificate from the NMPA for its Isosorbide Dinitrate Injection. This product is indicated for unstable angina and vasospastic angina. The approval enhances the company's cardiovascular product portfolio and promotes an integrated industrial chain from raw materials to finished products.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002923 Securities Abbreviation: Rundu Co., Ltd. Announcement No.: 2026-043

Zhuhai Rundu Pharmaceutical Co., Ltd.

Announcement on Obtaining Drug Registration Certificate for Isosorbide Dinitrate Injection

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from false records, misleading statements, or major omissions.

Zhuhai Rundu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") recently received a "Drug Registration Certificate" issued by the National Medical Products Administration. The relevant situation is hereby announced as follows:

I. Basic Information of the Drug

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.